You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Ophthalmic Solutions

Showing 26 - 50 of 2,869
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Open Angle Glaucoma, Ocular Hypertension Trial in Japan (STN1012600 ophthalmic solution 0.002%, STN1012600 ophthalmic solution

Recruiting
  • Open Angle Glaucoma, Ocular Hypertension
  • STN1012600 ophthalmic solution 0.002%
  • STN1012600 ophthalmic solution 0.002% and Timolol ophthalmic solution 0.5%
  • Aichi, Japan
  • +15 more
Aug 16, 2022

Presbyopia Trial in Glendale, Memphis (0.1% STN1013600 ophthalmic solution, 0.3% STN1013600 ophthalmic solution, Placebo)

Recruiting
  • Presbyopia
  • 0.1% STN1013600 ophthalmic solution
  • +2 more
  • Glendale, California
  • +1 more
Jan 12, 2023

Allergic Conjunctivitis Trial in Phoenix, Andover, Memphis (Brimonidine tartrate 0.025% / ketotifen fumarate 0.035% combo,

Not yet recruiting
  • Allergic Conjunctivitis
  • Brimonidine tartrate 0.025% / ketotifen fumarate 0.035% combo
  • +3 more
  • Phoenix, Arizona
  • +2 more
Nov 9, 2022

Dry Eye Disease Trial in Bellaire (Topical spironolactone ophthalmic solution, 0.005 mg/cc, Placebo)

Not yet recruiting
  • Dry Eye Disease
  • Topical spironolactone ophthalmic solution, 0.005 mg/cc
  • Placebo
  • Bellaire, Texas
    Richard W Yee, MD PLLC
Aug 16, 2023

Dry Eye Trial in Raynham (Reproxalap Ophthalmic Solution (0.25%), Vehicle Ophthalmic Solution)

Completed
  • Dry Eye
  • Reproxalap Ophthalmic Solution (0.25%)
  • Vehicle Ophthalmic Solution
  • Raynham, Massachusetts
    Andover Eye Associates (Raynham)
Aug 2, 2022

Dry Eye Disease Trial in Durham (SY-201 Ophthalmic Solution 2.0%, SY-201 Ophthalmic Solution 1.0%, SY-201 Ophthalmic Solution

Recruiting
  • Dry Eye Disease
  • SY-201 Ophthalmic Solution 2.0%
  • +3 more
  • Durham, North Carolina
    Lexitas
Jul 27, 2022

Dry Eye Syndromes Trial in Andover (IC265 Ophthalmic Solution 1%, Placebo Ophthalmic Solution (Vehicle))

Not yet recruiting
  • Dry Eye Syndromes
  • IC265 Ophthalmic Solution 1%
  • Placebo Ophthalmic Solution (Vehicle)
  • Andover, Massachusetts
    Iacta Selected Site
Aug 8, 2023

Allergic Conjunctivitis, Dry Eye, Dry Eye Disease Trial in Catanzaro (Eye drops for itchy and water eyes)

Completed
  • Allergic Conjunctivitis
  • +2 more
  • Eye drops for itchy and water eyes
  • Catanzaro, CZ, Italy
    Azienda Ospedaliera Policlinico Mater Domini - Università Magna
Apr 11, 2023

Dry Eye Syndromes Trial in Mississauga (Reproxalap Ophthalmic Solution (0.25%), Vehicle Ophthalmic Solution)

Recruiting
  • Dry Eye Syndromes
  • Reproxalap Ophthalmic Solution (0.25%)
  • Vehicle Ophthalmic Solution
  • Mississauga, Ontario, Canada
    Cliantha Research
Jun 22, 2022

Glaucoma, Primary Open Angle, Ocular Hypertension Trial in Newport Beach (Study Treatment 1 WB007, Study Treatment 2 WB007,

Active, not recruiting
  • Glaucoma, Primary Open Angle
  • Ocular Hypertension
  • Study Treatment 1 WB007
  • +3 more
  • Newport Beach, California
    Eye Research Foundation
Dec 30, 2022

Acute Bacterial Conjunctivitis Trial (IVIEW-1201, Ofloxacin Eye Drops)

Not yet recruiting
  • Acute Bacterial Conjunctivitis
  • (no location specified)
Apr 13, 2023

Glaucoma, Open-Angle, Ocular Hypertension Trial in United States (Test - Bimatoprost 0.01% Ophthalmic Solution, Reference -

Recruiting
  • Glaucoma, Open-Angle
  • Ocular Hypertension
  • Test - Bimatoprost 0.01% Ophthalmic Solution
  • Reference - LUMIGAN® (Bimatoprost 0.01% Ophthalmic Solution)
  • Newport Beach, California
  • +8 more
Aug 9, 2022

Primary Open Angle Glaucoma, Ocular Hypertension Trial in Japan (STN1012600 ophthalmic solution 0.002%, Latanoprost ophthalmic

Recruiting
  • Primary Open Angle Glaucoma, Ocular Hypertension
  • STN1012600 ophthalmic solution 0.002%
  • Latanoprost ophthalmic solution 0.005%
  • Aichi, Japan
  • +42 more
Aug 9, 2022

Dry Eye Trial in New York (Lifitegrast 5% Ophthalmic Solution, Lifitegrast Ophthalmic Solution Vehicle)

Not yet recruiting
  • Dry Eye
  • Lifitegrast 5% Ophthalmic Solution
  • Lifitegrast Ophthalmic Solution Vehicle
  • New York, New York
    State University of New York College of Optometry Clinical Visio
Aug 16, 2022

Dry Eye Disease Trial in United States (A197 Ophthalmic Solution, A197 Vehicle Control, Active Comparator)

Active, not recruiting
  • Dry Eye Disease
  • A197 Ophthalmic Solution
  • +2 more
  • Birmingham, Alabama
  • +23 more
Nov 8, 2022

Conjunctivitis, Allergic Trial in United States (ADX-102 Ophthalmic Drops (0.5%), ADX-102 Ophthalmic Drops (0.1%), Vehicle of

Completed
Has Results
  • Conjunctivitis, Allergic
  • ADX-102 Ophthalmic Drops (0.5%)
  • +2 more
  • Morrow, Georgia
  • +4 more
Dec 14, 2022

Allergic Conjunctivitis Trial in Mississauga (Reproxalap Ophthalmic Solution (0.25%), Vehicle Ophthalmic Solution)

Recruiting
  • Allergic Conjunctivitis
  • Reproxalap Ophthalmic Solution (0.25%)
  • Vehicle Ophthalmic Solution
  • Mississauga, Ontario, Canada
    Cliantha Research
May 5, 2022

Glaucoma, Open-Angle, Ocular Hypertension Trial in Argentina (Dorzolamide / Timolol Ophthalmic Solution, dorzolamide/timolol)

Recruiting
  • Glaucoma, Open-Angle
  • Ocular Hypertension
  • Olivos, Buenos Aires, Argentina
  • +5 more
May 10, 2023

Dry Eye Trial in United States (0.25% HL036 Ophthalmic Solution, Placebo)

Completed
  • Dry Eye
  • 0.25% HL036 Ophthalmic Solution
  • Placebo
  • Phoenix, Arizona
  • +9 more
Jan 4, 2023

Allergic Conjunctivitis Trial in United States (Reproxalap Ophthalmic Solution (0.25%), Reproxalap Ophthalmic Solution (0.5%),

Completed
  • Allergic Conjunctivitis
  • Reproxalap Ophthalmic Solution (0.25%)
  • +2 more
  • Phoenix, Arizona
  • +6 more
Oct 30, 2019

Dry Eye Disease Trial in United States (CequaTM (Cyclosporine 0.09%) ophthalmic solution)

Completed
  • Dry Eye Disease
  • CequaTM (Cyclosporine 0.09%) ophthalmic solution
  • Fort Myers, Florida
  • +4 more
Sep 8, 2022

Dry Eye Trial in United States (0.3% YP-P10 Ophthalmic Solution, 1% YP-P10 Ophthalmic Solution, YP-P10 Placebo Ophthalmic

Recruiting
  • Dry Eye
  • 0.3% YP-P10 Ophthalmic Solution
  • +2 more
  • Phoenix, Arizona
  • +6 more
Jul 15, 2022

Elevated Intraocular Pressure Trial in United States (Latanoprost ophthalmic solution, 0.005%, TC-002 latanoprost ophthalmic

Active, not recruiting
  • Elevated Intraocular Pressure
  • Latanoprost ophthalmic solution, 0.005%
  • TC-002 latanoprost ophthalmic solution, 0.005%
  • Garden Grove, California
  • +19 more
May 23, 2022

Epiphora, Dacryostenosis, Dacryocystitis Trial in New Orleans (Proparacaine Hydrochloride ophthalmic solution, USP 0.5%,

Recruiting
  • Epiphora
  • +2 more
  • Proparacaine Hydrochloride ophthalmic solution, USP 0.5%
  • Balanced salt solution
  • New Orleans, Louisiana
    Louisiana State University Health Sciences Center
Dec 15, 2022

Dry Eye Disease Trial in United States (CyclASol topical ocular, eye drops, Vehicle topical ocular, eye drops)

Completed
Has Results
  • Dry Eye Disease
  • CyclASol topical ocular, eye drops
  • Vehicle topical ocular, eye drops
  • Newport Beach, California
  • +8 more
Dec 21, 2022